Get started
Author

Marta Smoter

Observed names: M Smoter, M. Smoter, MARTA SMOTER
OpenAlex ID: A5069700092
Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer
2014 · Lubomir Bodnar, Aleksandra Stanczak, et al. · Journal of Ovarian Research · 80
PDF
The role of Tau protein in resistance to paclitaxel
2011 · Marta Smoter, Lubomir Bodnar, et al. · Cancer Chemotherapy and Pharmacology · 74
PDF
Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy
2013 · Marta Smoter, Lubomir Bodnar, et al. · Journal of Experimental & Clinical Cancer Research · 63
PDF
Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: The prediction value of ERCC1 and Tau expression
2014 · KARINA DAHL STEFFENSEN, MARTA SMOTER, et al. · International Journal of Oncology · 34
PDF
Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
2013 · Marta Rokita, Rafał Stec, et al. · OncoTargets and Therapy · 34
PDF
Cystatin C as a Parameter of Glomerular Filtration Rate in Patients with Ovarian Cancer
2010 · Lubomir Bodnar, Gabriel Benedykt Wcislo, et al. · Kidney & Blood Pressure Research · 34
Metastatic colorectal cancer in the elderly: An overview of the systemic treatment modalities (Review)
2010 · RAFAŁ STEC, LUBOMIR BODNAR, et al. · Oncology Letters · 14
PDF
Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer
2015 · RAFAŁ STEC, ALEKSANDRA SEMENIUK-WOJTAŚ, et al. · Oncology Letters · 13
PDF
K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy
2012 · Rafał Stec, Lubomir Bodnar, et al. · Cancer Biology & Therapy · 13
Mitomycin C and High-Dose 5-Fluorouracil With Folinic Acid as a Therapeutic Option for Heavily Pretreated Patients With Metastatic Colorectal Cancer: Prospective Phase II Trial
2014 · Rafał Stec, Lubomir Bodnar, et al. · The Oncologist · 8
PDF
Salvage therapy with topotecan in heavily pretreated ovarian cancer patients
2008 · Lubomir Bodnar, Gabriel Wcislo, et al. · Journal of Cancer Research and Clinical Oncology · 6
Serum TRAIL levels in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy. A pilot study.
2011 · A Gasowska-Bodnar, L Bodnar, et al. · PubMed · 2
Optimal chemotherapy treatment for patients with advanced colorectal cancer
2011 · Rafał Stec, Lubomir Bodnar, et al. · Współczesna Onkologia · 2
PDF
Tau expression as a predictive marker in ovarian cancer patients (pts) treated with platinum/paclitaxel chemotherapy
2009 · M. Smoter, B. Grala, et al. · Journal of Clinical Oncology · 1
Long-Term Remission after Erlotinib Therapy in an Elderly Patient with Advanced Non-small Cell Lung Cancer. Case Report and Conclusions for Clinical Practice
2008 · Renata Duchnowska, Anna Siemiątkowska, et al. · Advances in respiratory medicine · 1
PDF
Role of Genetic Variants in the PI3K/AKT/MTOR Pathway in Renal Cell Carcinoma Patients Treated with Everolimus- A Pilot Study
2012 · L. Bodnar, R. Stec, et al. · Annals of Oncology
M-TOR inhibitors in the treatment of advanced renal cell carcinoma
2011 · Rafał Stec, Michał Mączewski, et al. · Współczesna Onkologia
PDF
Bevacizumab plus irinotecan in treatment of recurrent brain gliomas
2010 · Rafał Stec, Lubomir Bodnar, et al. · Współczesna Onkologia
PDF
Works count: 20
Citation count: 379
H-index: 9
I10-index: 9
Year
Topic
Type